Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Colorcon
Healthtrust
Chinese Patent Office
US Army
Cantor Fitzgerald
Accenture
Baxter
Federal Trade Commission

Generated: June 18, 2018

DrugPatentWatch Database Preview

PROSTAPHLIN Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Prostaphlin, and what generic alternatives are available?

Prostaphlin is a drug marketed by Apothecon and is included in two NDAs.

The generic ingredient in PROSTAPHLIN is oxacillin sodium. There are thirty-eight drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the oxacillin sodium profile page.
Summary for PROSTAPHLIN
Drug patent expirations by year for PROSTAPHLIN
Medical Subject Heading (MeSH) Categories for PROSTAPHLIN
Synonyms for PROSTAPHLIN
(2S,5R,6R)-3,3-dimethyl-6-(5-methyl-3-phenyl-1,2-oxazole-4-amido)-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2S,5R,6R)-3,3-dimethyl-6-[(5-methyl-3-phenyl-1,2-oxazole-4-carbonyl)amino]-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2S,5R,6R)-3,3-dimethyl-6-[(5-methyl-3-phenyl-isoxazole-4-carbonyl)amino]-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2S,5R,6R)-3,3-dimethyl-6-{[(5-methyl-3-phenylisoxazol-4-yl)carbonyl]amino}-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(5-methyl-3-phenyl-4-isoxazolyl)penicillin
1173-88-2
1173-88-2 (anhydrous monosodium salt)
2,2-dimethyl-6beta-(5-methyl-3-phenyl-1,2-oxazole-4-carboxamido)penam-3alpha-carboxylic acid
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-6-(((5-methyl-3-phenyl-4-isoxazolyl)carbonyl)amino)-7-oxo-, (2S-(2alpha,5alpha,6beta))-
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-6-(5-methyl-3-phenyl-4-isoxazolecarboxamide)-7-oxo-
4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3,3-dimethyl-6-(((5-methyl-3-phenyl-4-isoxazolyl)carbonyl)amino)-7-oxo-, (2S-(2.alpha.,5.alpha.,6.beta.))-
4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3,3-dimethyl-6-[[(5-methyl-3-phenyl-4-isoxazolyl)carbonyl]amino]-7-oxo-, (2S,5R,6R)-
5-Methyl-3-phenyl-4-isooxazolylpenicillin
5-Methyl-3-phenyl-4-isoxazolyl-penicillin
66-79-5
6beta-(5-methyl-3-phenylisoxazol-4-yl)penicillanic acid
7240-38-2 (monosodium salt, monohydrate)
AC1L1M00
AJ-46428
API0004686
Bactocill
Bactocill (TN)
BDBM50350483
BRD-K96786677-236-01-6
C07334
C19H19N3O5S
CHEBI:7809
CHEMBL819
D08307
D0MB8I
DB00713
DTXSID8023397
EINECS 200-635-5
Epitope ID:181859
HE066851
HE377532
LS-149809
MPi-PC
MPI-penicillin
Ossacillina
Ossacillina [DCIT]
Oxacilina
Oxacilina (TN)
Oxacilina [INN-Spanish]
oxacillin
Oxacillin (INN)
Oxacillin [INN:BAN]
OXACILLIN SODIUM
Oxacillin, Monosodium Salt, Anhydrous
Oxacilline
Oxacilline [INN-French]
Oxacillinum
Oxacillinum [INN-Latin]
Oxazocillin
Oxazocilline
Penicillin, (5-methyl-3-phenyl-4-isoxazolyl)-
Penicillin, Methylphenylisoxazolyl
Prostaphlyn
SCHEMBL3817
Sodium oxacillin
UH95VD7V76
UNII-UH95VD7V76
UWYHMGVUTGAWSP-JKIFEVAISA-N
X6829
ZINC3875439

US Patents and Regulatory Information for PROSTAPHLIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apothecon PROSTAPHLIN oxacillin sodium CAPSULE;ORAL 050118-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Apothecon PROSTAPHLIN oxacillin sodium FOR SOLUTION;ORAL 050194-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Citi
UBS
Deloitte
Accenture
US Army
McKinsey
Teva
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.